← Hims & Hers Health, Inc. HIMS
Market Price
$28.14
Market Cap
$6.66B
P/E Ratio
55.18
Revenue (FY 2025)
↑59.0% YoY
$2.35B
3-Yr CAGR: 64.5%
Net Income
↑1.8% YoY
$128.37M
Net Margin: 5.5%
Free Cash Flow
↓-64.7% YoY
$73.96M
FCF Yield: 1.11%
EPS (Diluted)
↓-3.8% YoY
$0.51
Basic: $0.57
Return on Equity
Efficiency
23.7%
ROA: 116.7%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (HIMS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2019 | — | — | — | — | — | — | — | $-74.9M | — | — |
| FY 2020 | $148.8M | — | $115.5M | $-3.0M | — | $-0.96 | — | $-0.8M | — | — |
| FY 2021 | $271.9M | +82.8% | $204.5M | $-107.7M | -3,430.9% | $-0.58 | +39.6% | $-34.4M | — | — |
| FY 2022 | $526.9M | +93.8% | $408.7M | $-65.7M | +39.0% | $-0.32 | +44.8% | $-26.5M | $-29.2M | — |
| FY 2023 | $872.0M | +65.5% | $714.9M | $-23.5M | +64.1% | $-0.11 | +65.6% | $73.5M | $56.3M | +292.4% |
| FY 2024 | $1,476.5M | +69.3% | $1,173.1M | $126.0M | +635.3% | $0.53 | +581.8% | $251.1M | $209.4M | +272.2% |
| FY 2025 | $2,347.6M | +59.0% | $1,733.4M | $128.4M | +1.8% | $0.51 | -3.8% | $300.0M | $74.0M | -64.7% |
Valuation
Market Price
$28.14
Market Cap
$6.66B
Enterprise Value
N/A
P/E Ratio
55.18
P/B Ratio
12.04
FCF Yield
1.11%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
73.84%
Operating Margin
4.50%
Net Margin
5.47%
Return on Equity (ROE)
23.73%
Return on Assets (ROA)
116.68%
Asset Turnover
21.34x
Revenue 3-Yr CAGR
64.55%
Financial Health & Liquidity
Current Ratio
1.40
Cash Ratio
2.91
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$228.62M
Total Debt
N/A
Book Value / Share
$2.34
Cash Flow Efficiency
Operating Cash Flow
$300.01M
Capital Expenditures (CapEx)
$226.04M
Free Cash Flow
$73.96M
OCF / Revenue
12.78%
FCF / Revenue
3.15%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$0.51
EPS (Basic)
$0.57
Dividends / Share
N/A
Book Value / Share
$2.34
EPS YoY Growth
-3.77%
Balance Sheet (FY 2025)
Total Assets
$110.02M
Total Liabilities
$78.52M
Stockholders' Equity
$540.93M
Current Assets
$110.02M
Current Liabilities
$78.52M